Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Massarotti

Showing results (21-30 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Immunopathology and Pharmacology|July 13, 2007
Interstitial lung disease in systemic sclerosisB Marasini, L Belloli, M Massarotti
International Journal of Immunopathology and Pharmacology|January 4, 2006
Scleroderma heart diseaseB Marasini, M Massarotti, R Cossutta
Rheumatology (Oxford, England)|December 11, 2012
The new ACR/EULAR classification criteria for RA: how are the new criteria performing in the clinic?Vivian P Bykerk, Elena M Massarotti
Rivista Di Neurologia|July 1, 1970
[EEG abnormalities in infantile hydrocephalic subjects after ventriculo-atrial shunts]F Marossero, M Massarotti, A Migliore
Rheumatology (Oxford, England)|December 11, 2012
The new ACR/EULAR remission criteria: rationale for developing new criteria for remissionVivian P Bykerk, Elena M Massarotti
Arthritis Research & Therapy|November 16, 2013
The potential role of ‘non-rheumatic’ therapies in rheumatic diseaseElena M Massarotti, Daniel H Solomon
Journal of Neurosurgical Sciences|January 1, 1974
Concentrations of 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with intracranial hypertensionM Massarotti, E Zorzi, G Toffano
European Neurology|January 1, 1978
5-Hydroxyindoleacetic acid and homovanillic acid in human cerebrospinal fluid below partial and complete spinal subarachnoid blockM Massarotti, P Roccella, G Toffano
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Editorial: Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?Elena M Massarotti, Heather G Allore, Karen Costenbader
International Journal of Immunopathology and Pharmacology|October 14, 2009
Systemic sclerosis and cancerB Marasini, L Conciato, L Belloli, et al.
Pageof 8

Showing results (21-30 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Immunopathology and Pharmacology|July 13, 2007
Interstitial lung disease in systemic sclerosisB Marasini, L Belloli, M Massarotti
International Journal of Immunopathology and Pharmacology|January 4, 2006
Scleroderma heart diseaseB Marasini, M Massarotti, R Cossutta
Rheumatology (Oxford, England)|December 11, 2012
The new ACR/EULAR classification criteria for RA: how are the new criteria performing in the clinic?Vivian P Bykerk, Elena M Massarotti
Rivista Di Neurologia|July 1, 1970
[EEG abnormalities in infantile hydrocephalic subjects after ventriculo-atrial shunts]F Marossero, M Massarotti, A Migliore
Rheumatology (Oxford, England)|December 11, 2012
The new ACR/EULAR remission criteria: rationale for developing new criteria for remissionVivian P Bykerk, Elena M Massarotti
Arthritis Research & Therapy|November 16, 2013
The potential role of ‘non-rheumatic’ therapies in rheumatic diseaseElena M Massarotti, Daniel H Solomon
Journal of Neurosurgical Sciences|January 1, 1974
Concentrations of 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with intracranial hypertensionM Massarotti, E Zorzi, G Toffano
European Neurology|January 1, 1978
5-Hydroxyindoleacetic acid and homovanillic acid in human cerebrospinal fluid below partial and complete spinal subarachnoid blockM Massarotti, P Roccella, G Toffano
Arthritis & Rheumatology (Hoboken, N.J.)|November 19, 2016
Editorial: Interferon-Targeted Therapy for Systemic Lupus Erythematosus: Are the Trials on Target?Elena M Massarotti, Heather G Allore, Karen Costenbader
International Journal of Immunopathology and Pharmacology|October 14, 2009
Systemic sclerosis and cancerB Marasini, L Conciato, L Belloli, et al.
Pageof 8